Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (141-150 of 233) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi TrialMassimo Federico, Stefano Luminari, Emilio Iannitto, et al.
British Journal of Haematology|February 24, 2024
Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019-2021Yana Stepanishyna, Martina Manni, Monica Civallero, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trialEmilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
JCO Global Oncology|May 5, 2025
Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort StudyMaria Elena Cabrera, Monica Civallero, Yana Stepanishyna, et al.
The Lancet. Oncology|December 14, 2011
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohortsHeikki Joensuu, Aki Vehtari, Jaakko Riihimäki, et al.
Preventive Medicine|March 31, 2015
Changes in cervical cancer incidence following the introduction of organized screening in ItalyDiego Serraino, Andrea Gini, Martina Taborelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana LinfomiMassimo Federico, Stefano Luminari, Alessandra Dondi, et al.
American Journal of Hematology|October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana LinfomiGiuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Tumori|June 14, 2005
National estimates of cancer patients survival in Italy: a model-based methodRiccardo Inghelmann, Enrico Grande, Silvia Francisci, et al.
American Journal of Hematology|April 9, 2014
Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL studyMassimo Gentile, Giovanna Cutrona, Laura Mosca, et al.
Pageof 24

Showing results (141-150 of 233) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi TrialMassimo Federico, Stefano Luminari, Emilio Iannitto, et al.
British Journal of Haematology|February 24, 2024
Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019-2021Yana Stepanishyna, Martina Manni, Monica Civallero, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trialEmilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
JCO Global Oncology|May 5, 2025
Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort StudyMaria Elena Cabrera, Monica Civallero, Yana Stepanishyna, et al.
The Lancet. Oncology|December 14, 2011
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohortsHeikki Joensuu, Aki Vehtari, Jaakko Riihimäki, et al.
Preventive Medicine|March 31, 2015
Changes in cervical cancer incidence following the introduction of organized screening in ItalyDiego Serraino, Andrea Gini, Martina Taborelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana LinfomiMassimo Federico, Stefano Luminari, Alessandra Dondi, et al.
American Journal of Hematology|October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana LinfomiGiuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Tumori|June 14, 2005
National estimates of cancer patients survival in Italy: a model-based methodRiccardo Inghelmann, Enrico Grande, Silvia Francisci, et al.
American Journal of Hematology|April 9, 2014
Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL studyMassimo Gentile, Giovanna Cutrona, Laura Mosca, et al.
Pageof 24